Dual-release hydrocortisone for treatment of adrenal insufficiency: a systematic review

Endocrine. 2020 Mar;67(3):507-515. doi: 10.1007/s12020-020-02187-7. Epub 2020 Jan 11.

Abstract

Dual-release hydrocortisone is a new hydrocortisone formulation developed to improve the pharmacokinetic and the pharmacodynamic profiles and patient compliance. The aim of this review is to summarize the main knowledge on dual-release hydrocortisone, with particular attention to pharmacokinetics, metabolic and health-related quality-of-life aspects, bone health and drug safety.

Keywords: Adrenal insufficiency; Dual-release hydrocortisone; Metabolism; Pharmacokinetic.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Adrenal Insufficiency* / drug therapy
  • Drug Administration Schedule
  • Humans
  • Hydrocortisone* / therapeutic use
  • Quality of Life

Substances

  • Hydrocortisone